1. Miettinen M, and Lasota J. Gastrointestinal stromaltumors-definition, clinical, histological, immunohistochemical and molecular genetic features and differential diagnosis. Virchows Arch 2001:438:1-12.
2. Hirota S, Isozaki K, Moriyama Y et al. Gain-of-func-lion mutations of c-kit in human gastrointestinal stromaltumors. Science 1998:279:577-80.
3. Lux ML, Rubin BP, Biase TL et al. KIT extracellular and kinase domain mutations in gastrointestinal stromaltumors. Am J Pathol 2000:156:791-5.
4. Lasota J, Jasinski M, Salomo-Rikala M et al. Mutations in exon ll of c-kit occur preferentially in malignantversus benign gastrointestinal stromal tumors and do notoccur in leiomyomas and leiomyosarcomas. Am J Pathol1999;154:53-60.
5. Drucker BJ, Tamura S, Buchdunger E et al. Effects ofaselective inhibitor of the Abl tyrosine kinase on the growthof Bcr-Abl positive cells. Nat Med 1996:2:561-6.